載入...
Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer
Increasing interest in repurposing the diabetic medication metformin for cancer treatment has raised important questions about the translation of promising preclinical findings to therapeutic efficacy, especially in non-diabetic patients. A significant limitation of the findings to date is the use o...
Na minha lista:
| 發表在: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Impact Journals LLC
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4695136/ https://ncbi.nlm.nih.gov/pubmed/26172303 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|